Recall archive / FDA company announcement
B. Braun: Lactated Ringer’s Injection USP 1000 mL/0.9% Sodium Chloride Injection USP 1000 mL — FDA announcement Aug 19, 2025
Published notice; closure not supplied
A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.
Source date Aug 19, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Lactated Ringer’s Injection USP 1000 mL/0.9% Sodium Chloride Injection USP 1000 mL
- Reason
- Due to the presence of particulate matter.
- Classification
- Not supplied
- Recalling firm
- B. Braun Medical, Inc.
- Quantity
- Not supplied
- Agency-reported status
- Company recall announcement
- Source record identifier
- fd343da59118f998
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Product Catalog Number | NDC Number | Product Description | Lot Number | Distribution Range | Expiration Date | Region Distributed; E7500 | 0264-7750-07 | Lactated Ringers Injection USP 1000 mL | J4S807 | 26DEC2024 - 10APR 2025 | 31MAY2027 | US; E8000 | 0264-7800-09 | 0.9% Sodium Chloride Injection USP 1000ML | V3K770 | 15NOV2023 - 25 SEP2024 | 31JAN2026 | US |
Match all identifying details in the current notice. A brand name alone is not enough.
Product tables from the announcement
These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.
| Product Catalog Number | NDC Number | Product Description | Lot Number | Distribution Range | Expiration Date | Region Distributed |
|---|---|---|---|---|---|---|
| E7500 | 0264-7750-07 | Lactated Ringers Injection USP 1000 mL | J4S807 | 26DEC2024 - 10APR 2025 | 31MAY2027 | US |
| E8000 | 0264-7800-09 | 0.9% Sodium Chloride Injection USP 1000ML | V3K770 | 15NOV2023 - 25 SEP2024 | 31JAN2026 | US |
Announcement retrieved Oct 1, 2026. Official announcement.
Distribution
These products were distributed nationwide via distributors.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- North Dakota
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
Dates in the source
- Fda listing date
- Aug 19, 2025
- Company announcement date
- Aug 19, 2025
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.